Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polycation-based nanoparticle delivery for improved RNA interference therapeutics.

Kenneth A Howard1, Jørgen Kjems

  • 1University of Aarhus, Interdisciplinary Nanoscience Center (iNANO) and Department of Molecular Biology, 8000 Aarhus, Denmark. kenh@inano.dk

Expert Opinion on Biological Therapy
|November 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosis.

iScience·2026
Same author

The history and function of a circular RNA.

Nature communications·2026
Same author

Optimizing C14120-based LNPs for <i>in vitro</i> and <i>in vivo</i> mRNA delivery.

Molecular therapy. Nucleic acids·2026
Same author

Scalable Production of DNA-Probe-Functionalized Heteromeric MspA Nanopores for Biosensing.

ACS applied materials & interfaces·2026
Same author

Global protein profiling of human milk using pre-enriched RNA-sequence libraries.

Scientific reports·2026
Same author

Biomarker-directed aptamer panels for diagnosis and differentiation of neuroendocrine tumors.

Journal of neuroendocrinology·2026
Same journal

Biologic modulation of ineffective erythropoiesis in thalassemia: mechanisms, clinical practice, and future targets.

Expert opinion on biological therapy·2026
Same journal

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Expert opinion on biological therapy·2026
Same journal

Type 2 inflammation and biologics: a twenty-year journey.

Expert opinion on biological therapy·2026
Same journal

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026
Same journal

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same journal

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
See all related articles

Polymeric nanoparticles (polyplexes) offer a promising method for delivering small-interfering RNA (siRNA) to silence disease-causing genes. This approach enhances therapeutic potential through improved delivery and cellular uptake for genetic medicine.

Area of Science:

  • Biotechnology
  • Genetic Medicine
  • Nanotechnology

Background:

  • RNA interference (RNAi) using small-interfering RNA (siRNA) presents a novel genetic medicine strategy for gene silencing in diseases.
  • Effective delivery of siRNA is crucial for its therapeutic application, requiring efficient cellular uptake and intracellular trafficking.
  • Polymeric nanoparticles, or polyplexes, formed from polycations and siRNA, are being explored for targeted delivery.

Purpose of the Study:

  • To review the application of polyplexes for in vivo delivery of synthetic siRNA.
  • To focus on systemic and mucosal delivery routes and their associated in vivo requirements.
  • To discuss future directions, including stimuli-responsive systems, for advancing RNA-based therapeutics.

Main Methods:

Related Experiment Videos

  • Review of existing literature on polyplex-mediated siRNA delivery.
  • Analysis of in vivo delivery strategies, including systemic and mucosal routes.
  • Discussion of intracellular trafficking mechanisms and stimuli-responsive systems.

    • Main Results:

    • Polyplexes facilitate site-specific delivery, cellular uptake, and intracellular trafficking of siRNA.
    • Systemic and mucosal routes are key considerations for in vivo siRNA delivery using polyplexes.
    • Stimuli-responsive systems show potential for enhancing intracellular siRNA release and therapeutic efficacy.

    Conclusions:

    • Polymeric nanoparticles (polyplexes) are effective vehicles for in vivo siRNA delivery, improving therapeutic potential.
    • Further development of stimuli-responsive systems is essential for optimizing intracellular siRNA trafficking and clinical translation.
    • Polyplex-based siRNA delivery holds significant promise for the future of RNA-based clinical therapeutics.